211 related articles for article (PubMed ID: 26071461)
21. Therapy-related myeloid neoplasms.
Czader M; Orazi A
Am J Clin Pathol; 2009 Sep; 132(3):410-25. PubMed ID: 19687318
[TBL] [Abstract][Full Text] [Related]
22. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
24. Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431.
Mast KJ; Taub JW; Alonzo TA; Gamis AS; Mosse CA; Mathew P; Berman JN; Wang YC; Jones HM; Campana D; Coustan-Smith E; Raimondi SC; Hirsch B; Hitzler JK; Head DR
Arch Pathol Lab Med; 2020 Apr; 144(4):466-472. PubMed ID: 31429606
[TBL] [Abstract][Full Text] [Related]
25. Erythroleukemia and myelodysplastic syndromes: an historical appraisal and a personal view.
Michiels JJ
Leuk Lymphoma; 1993 Jan; 9(1-2):27-34. PubMed ID: 8477198
[No Abstract] [Full Text] [Related]
26. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts.
Wang SA; Patel KP; Pozdnyakova O; Peng J; Zuo Z; Dal Cin P; Steensma DP; Hasserjian RP
Mod Pathol; 2016 Oct; 29(10):1221-31. PubMed ID: 27443511
[TBL] [Abstract][Full Text] [Related]
27. Erythroid proliferations in myeloid neoplasms.
Wang SA; Hasserjian RP
Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053
[TBL] [Abstract][Full Text] [Related]
28. Skeletal manifestations of pediatric acute megakaryoblastic leukemia.
Athale UH; Kaste SC; Razzouk BI; Rubnitz JE; Ribeiro RC
J Pediatr Hematol Oncol; 2002 Oct; 24(7):561-5. PubMed ID: 12368696
[TBL] [Abstract][Full Text] [Related]
29. [Erythroleukemias. Recategorization according to the World Health Organization's criteria].
Peruzzo LB; Bertone MC; Mathey MD; Rossi JG; Baialardo EM; Felice MS
Medicina (B Aires); 2019; 79(1):1-5. PubMed ID: 30694182
[TBL] [Abstract][Full Text] [Related]
30. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.
Bennett JM
Int J Hematol; 2000 Aug; 72(2):131-3. PubMed ID: 11039659
[TBL] [Abstract][Full Text] [Related]
31. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
[TBL] [Abstract][Full Text] [Related]
32. The disappearance of acute erythroid leukemia: An act of legerdemain at the World Health Organization.
Lichtman MA
Blood Cells Mol Dis; 2016 Oct; 61():54-7. PubMed ID: 27667167
[No Abstract] [Full Text] [Related]
33. Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
Vardiman J; Reichard K
Am J Clin Pathol; 2015 Jul; 144(1):29-43. PubMed ID: 26071460
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndromes.
Orazi A; Czader MB
Am J Clin Pathol; 2009 Aug; 132(2):290-305. PubMed ID: 19605823
[TBL] [Abstract][Full Text] [Related]
35. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
36. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
37. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
38. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia.
Drexler HG; Matsuo Y; MacLeod RA
Leuk Res; 2004 Dec; 28(12):1243-51. PubMed ID: 15475063
[TBL] [Abstract][Full Text] [Related]
39. Pure erythroid leukemia presenting in a HIV-positive patient.
Oberley MJ; Yang DT
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e35-8. PubMed ID: 24220619
[No Abstract] [Full Text] [Related]
40. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
